Research report on pharmacy market trends and global forecasts

Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) — The “Pharmacy Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Pharmacy, Type of Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e The Report” Pharmacy platforms, therapeutic area, key players and geographical region” has been added ResearchAndMarkets.com Offer.

The pharmacy market is estimated to be worth $2.4 trillion in 2024 and is growing at a CAGR of 5% during the forecast period 2024-2035.

This report provides an overview, comprehensive insight into the pharmacy industry and highlights technological advances. It highlights the involvement of regulators and provides insights into the current state and future prospects of the pharmacy sector. It provides a comprehensive analysis of several relevant factors affecting the growth of the market including key drivers, restraints, emerging opportunities and existing challenges and provides a detailed understanding of the market dynamics and possible future development.

The latest research study covers the pharmacy industry and examines trends, market analysis, competitive landscape, company competitiveness, value chain, market impact and forecast opportunities. The increasing prevalence of chronic diseases and the aging population, as well as the growing demand for home care, are driving the adoption of online pharmacies.

According to the U.S. Department of Health and Human Services, approximately 133 million Americans suffer from at least one chronic disease. To combat this problem, pharmacies offer a wide range of prescription medications, over-the-counter products, medical devices, and health and wellness products for treatment. Many pharmacies have become “one-stop shops,” offering a variety of products beyond traditional pharmacy services. The global pharmacy industry is shifting towards personalization, sustainability and online pharmacy services.

Pharmacies are adopting automation and digitalization strategies to improve efficiency, patient safety and personalized services. The COVID-19 pandemic has accelerated industry growth as pharmacies offer testing and vaccination services. Pharmacists now offer additional services such as glucose testing, cholesterol screening and vaccinations in community pharmacies. Loyalty programs are becoming increasingly popular in the US, with 33% of consumers participating in new programs in 2022. Globally, 57% of consumers used their loyalty points to save money in 2022.

Online pharmacies are experiencing rapid growth worldwide, driven by high Internet usage and patients' desire to reduce healthcare costs. However, the growth has also led to an increase in the illegal sale of unapproved and misbranded medicines. Different regulatory frameworks have led to different models of online pharmacies, with prescription models in the US and over-the-counter models in Europe.

As the industry continues to evolve, pharmacies are turning to strategies like micro-fulfillment centers to meet prescription drug demand. The shift towards online pharmacy services is expected to lead to significant growth in the global pharmacy market value during the forecast period.

Key Benefits of Purchasing this Report

The report provides market leaders and new entrants with valuable insights into sales estimates for both the overall market and its sub-segments.
Stakeholders can use the report to improve their understanding of the competitive landscape, enabling improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with an overview of the pharmacy market and provides them with important information on key market drivers, barriers, opportunities and challenges.

Competitive landscape

Key Pharmacy Players: Overall Market Landscape
Analysis by year of founding
Analysis by company size
Analysis by headquarters location
Analysis by company ownership

Company Profiles: Leading Players

AS Watson
- Company overview
- Service portfolio
- Financial Information
- Current developments and future prospects
Cigna
CVS Health
Dr. Max
Kroger
Matsumoto Kiyoshi
Phoenix
Rite aid
Walgreens Boots Alliance
Well, pharmacy

Other leading players

Ahold Delhaize
Company overview
Service portfolio
Albertsons
Cardinal Health
Cosmos Pharmaceutical
Costco
Dirk Rossmann
Good Neighbor Pharmacy
healthcare market
Optimal
The Jean Coutu
Walmart

Main topics covered:

1. BACKGROUND
1.1. context
1.2. Project goals

2. RESEARCH METHOD
2.1. Chapter overview
2.2. Research assumptions
2.3. Project methodology
2.4. Forecasting methodology
2.5. Robust quality control
2.6. Important market segmentations
2.7. Important considerations
2.7.1. Demographics
2.7.2. Economic factors
2.7.3. Government regulations
2.7.4. Supply chain
2.7.5. COVID Impact
2.7.6. Market access
2.7.7. Health guidelines
2.7.8. Industry consolidation

3. ECONOMIC AND OTHER PROJECT-SPECIFIC CONSIDERATIONS
3.1. Chapter overview
3.2. Market dynamics
3.2.1. Period
3.2.1.1. Historical trends
3.2.1.2. Current and future estimates
3.2.2. Currency coverage and exchange rate
3.2.2.1. Major currencies influencing the market
3.2.2.2. Factors affecting currency fluctuations and exchange rates
3.2.2.3. Effects of exchange rate volatility on the market
3.2.2.4. Strategies to mitigate exchange rate risk
3.2.3. Trading Guidelines
3.2.3.1. Effects of trade barriers on the market
3.2.3.2. Strategies to mitigate the risks associated with trade barriers
3.2.4. recession
3.2.4.1. Historical analysis of past recessions and lessons learned
3.2.4.2. Evaluate current economic conditions and potential market impacts
3.2.5. inflation
3.2.5.1. Measuring and analyzing inflationary pressures in the economy
3.2.5.2. Possible effects of inflation on market development

4. SUMMARY

5. INTRODUCTION
5.1. An overview of the pharmaceutical industry
5.2. Key Regulatory Agencies
5.3. Technological advances in the pharmaceutical industry

6. Market Impact Analysis, Drivers, Constraints, Opportunities and Challenges
6.1. Market Drivers
6.2. Market Restrictions
6.3. Market opportunities
6.4. Market challenges
6.5. Diploma

7. GLOBAL PHARMACY MARKET
7.1. Assumptions and methodology
7.2. Global pharmacy market, by 2035
7.2.1. Scenario analysis
7.2.1.1. Conservative scenario
7.2.1.2. Optimistic scenario

8. PHARMACY MARKET, BY PHARMACY TYPE
8.1. Pharmacy market: distribution by pharmacy type, 2019, 2024 and 2035
8.1.1. Pharmacy market for retail pharmacies, by 2035
8.1.2. Pharmacy market for e-pharmacy, until 2035
8.1.3. Pharmacy market for hospital pharmacies, until 2035
8.1.4. Pharmacy market for other pharmacies, until 2035

9. PHARMACY MARKET, BY TYPE OF PRODUCT OFFERED
9.1. Pharmacy market: distribution by type of products offered, 2019, 2024 and 2035
9.1.1. Pharmacy market for medicines/pharmaceuticals, until 2035
9.1.2. Pharmacy market for medical devices, until 2035
9.1.3. Pharmacy market for other pharmacy products, until 2035

10. PHARMACY MARKET, SUBJECT TO AVAILABILITY
10.1. Pharmacy market: distribution according to availability, 2019, 2024 and 2035
10.1.1. Pharmacy market for prescription products, by 2035
10.1.2. Pharmacy market for non-prescription products, by 2035

11. PHARMACY MARKET BY TYPE OF DRUG
11.1. Pharmacy market: distribution by drug type, 2019, 2024 and 2035
11.1.1. Pharmacy market for branded/patented medicines, until 2035
11.1.2. Pharmacy market for generics, until 2035

12. PHARMACY MARKET BY TYPE OF DRUG MOLECULE
12.1. Pharmacy market: distribution by type of drug molecule in 2019, 2024 and 2035
12.1.1. Small molecule pharmacy market, by 2035
12.1.2. Pharmacy market for biologics, until 2035

13. Pharmacy market, by type of e-pharmacy platform
13.1. Pharmacy market: distribution by e-pharmacy platforms, 2019, 2024 and 2035
13.1.1. Pharmacy market for app-based platforms, by 2035
13.1.2. Pharmacy market for web-based platforms, by 2035

14. PHARMACY MARKET, BY THERAPY AREA
14.1. Pharmacy market: distribution by therapeutic area, 2019, 2024 and 2035
14.1.1. Pharmacy market for oncological diseases, by 2035
14.1.2. Pharmacy market for metabolic diseases, until 2035
14.1.3. Pharmacy market for autoimmune/inflammatory diseases, by 2035
14.1.4. Pharmacy market for respiratory diseases, by 2035
14.1.5. Pharmacy market for infectious diseases, by 2035
14.1.6. Pharmacy market for cardiovascular diseases, by 2035
14.1.7. Pharmacy market for neurological diseases, by 2035
14.1.8. Pharmacy market for dermatological diseases, until 2035
14.1.9. Pharmacy market for genetic diseases, by 2035
14.1.10. Pharmacy market for other diseases, until 2035

15. PHARMACY MARKET BY GEOGRAPHICAL REGION
15.1. Pharmacy market: distribution by geographical region, 2019, 2024 and 2035
15.2. Key highlights of distribution by geographic region

For more information about this report, see

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.